CIA BRASILEIRA DE DIS- ADR (CBD) Stock Price, Quote, News and Overview
NYSE:CBD - New York Stock Exchange, Inc. - US20440T3005 - ADR - Currency: USD
CBD Quote, Performance and Key Statistics
0.445
-0.01 (-3.05%)
The current stock price of CBD is 0.445 USD. In the past month the price decreased by -32.58%. In the past year, price decreased by -85.41%.
CBD Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| KR | KROGER CO | 15.93 | 47.15B | ||
| CASY | CASEY'S GENERAL STORES INC | 31.17 | 16.60B | ||
| SFM | SPROUTS FARMERS MARKET INC | 44.33 | 16.36B | ||
| ACI | ALBERTSONS COS INC - CLASS A | 9.56 | 12.87B | ||
| CART | MAPLEBEAR INC | 26.37 | 10.94B | ||
| TBBB | BBB FOODS INC-CLASS A | 231.15 | 3.43B | ||
| WMK | WEIS MARKETS INC | 20.54 | 2.26B | ||
| GO | GROCERY OUTLET HOLDING CORP | 20.57 | 1.54B | ||
| IMKTA | INGLES MARKETS INC-CLASS A | 15.18 | 1.20B | ||
| NGVC | NATURAL GROCERS BY VITAMIN C | 30.84 | 1.11B | ||
| DDL | DINGDONG CAYMAN LTD -SPN ADR | 13.58 | 559.82M | ||
| VLGEA | VILLAGE SUPER MARKET-CLASS A | 9.73 | 523.92M |
Related stock screener links
About CBD
Company Profile
Companhia Brasileira de Distribuição engages in the retail of food, clothing, home appliances, and other products through its chain of hypermarkets and supermarkets. The company is headquartered in Sao Paulo, Sao Paulo. The Firm, directly or through its subsidiaries, is engaged in the distribution of food, clothing, home appliances, electronics and other items through its chain of hypermarkets, supermarkets, specialized stores and department stores. The firm's activities are divided into three segments: Retail, Exito Group and Other Businesses. The Retail segment focuses on the banners Pao de Acucar, Minuto Pao de Acucar, Extra Hiper, Extra Supermercado and Mini Extra, among others. The company also includes the operation of gas stations and drugstores. The Exito Group segment consists of the operation of stores in Colombia, Uruguay and Argentina. The Other Businesses segment includes complementary businesses, such as the real estate, credit card, travel, insurance, mobile and money transfer, royalties, financial services, marketing and other services.
Company Info
CIA BRASILEIRA DE DIS- ADR
Av. Brigadeiro Luis Antonio 3142, Jardim Paulista
Sao Paulo SAO PAULO 01402 BR
CEO: Jorge Faical
Employees: 0
Company Website: https://www.gpari.com.br/
Phone: 551138860421
CIA BRASILEIRA DE DIS- ADR / CBD FAQ
What is the stock price of CIA BRASILEIRA DE DIS- ADR today?
The current stock price of CBD is 0.445 USD. The price decreased by -3.05% in the last trading session.
What is the ticker symbol for CIA BRASILEIRA DE DIS- ADR stock?
The exchange symbol of CIA BRASILEIRA DE DIS- ADR is CBD and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is CBD stock listed?
CBD stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for CIA BRASILEIRA DE DIS- ADR stock?
16 analysts have analysed CBD and the average price target is 1.53 USD. This implies a price increase of 244.19% is expected in the next year compared to the current price of 0.445. Check the CIA BRASILEIRA DE DIS- ADR stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is CIA BRASILEIRA DE DIS- ADR worth?
CIA BRASILEIRA DE DIS- ADR (CBD) has a market capitalization of 218.06M USD. This makes CBD a Micro Cap stock.
How many employees does CIA BRASILEIRA DE DIS- ADR have?
CIA BRASILEIRA DE DIS- ADR (CBD) currently has 0 employees.
What are the support and resistance levels for CIA BRASILEIRA DE DIS- ADR (CBD) stock?
CIA BRASILEIRA DE DIS- ADR (CBD) has a resistance level at 0.7. Check the full technical report for a detailed analysis of CBD support and resistance levels.
Is CIA BRASILEIRA DE DIS- ADR (CBD) expected to grow?
The Revenue of CIA BRASILEIRA DE DIS- ADR (CBD) is expected to grow by 8.97% in the next year. Check the estimates tab for more information on the CBD EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy CIA BRASILEIRA DE DIS- ADR (CBD) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of CBD, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of CBD, evaluating the profitability, health, valuation and growth aspects
- CIA BRASILEIRA DE DIS- ADR (CBD) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- CIA BRASILEIRA DE DIS- ADR (CBD) Sales and EPS estimates to see what analysts future expectations are.
- CIA BRASILEIRA DE DIS- ADR (CBD) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- CIA BRASILEIRA DE DIS- ADR (CBD) Insider and Institutional Ownership to learn about the owners and their transactions.
- CIA BRASILEIRA DE DIS- ADR (CBD) Stock Chart to make your own analysis
- CIA BRASILEIRA DE DIS- ADR (CBD) Latest news and press-releases to stay up to date.
Does CIA BRASILEIRA DE DIS- ADR (CBD) stock pay dividends?
CIA BRASILEIRA DE DIS- ADR (CBD) has a dividend yield of 13.41%. The yearly dividend amount is currently 0.41. Check the full fundamental report for a detailed analysis of CBD dividend history, reliability and sustainability.
When does CIA BRASILEIRA DE DIS- ADR (CBD) report earnings?
CIA BRASILEIRA DE DIS- ADR (CBD) will report earnings on 2024-05-01, after the market close.
What is the Price/Earnings (PE) ratio of CIA BRASILEIRA DE DIS- ADR (CBD)?
CIA BRASILEIRA DE DIS- ADR (CBD) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.86).
CBD Technical Analysis
CBD Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to CBD. Both the profitability and financial health of CBD have multiple concerns.
CBD Financial Highlights
Over the last trailing twelve months CBD reported a non-GAAP Earnings per Share(EPS) of -0.86. The EPS decreased by -1171.43% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -10.3% | ||
| ROE | -48.12% | ||
| Debt/Equity | 1.72 |
CBD Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 50% to CBD. The Buy consensus is the average rating of analysts ratings from 16 analysts.
For the next year, analysts expect an EPS growth of 83.74% and a revenue growth 8.97% for CBD